This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Climate-Related Capital Risk & Stress Testing 2023
October 2023
Venue TBCLondon

Erik Vynckier
Board Member at Foresters Friendly Society and Institute and Faculty of Actuaries

Profile

Erik Vynckier is Board member of Foresters Friendly Society since 2016, for whom he also chairs the Investment, With-Profits and Unit-Linked Committees following a career in banking, insurance, asset management and petrochemical industry. Erik restructured Foresters as Interim CEO in 2019.

Erik was Chief Investment Officer (Europe) for private equity group Eli Global LLC and Chief Investment Officer for European insurance clients at Alliance Bernstein. Erik has managed with-profits and annuity funds at Scottish Widows Investment Partnership (Aberdeen Standard Life) after managing the Group Risk Hub of Standard Life. Erik started in finance at Credit Suisse First Boston and HSBC, in equity program trading, quantitative development and asset-liability management for client balance sheets.

Erik was Chair of Research and Thought Leadership Board at the Institute and Faculty of Actuaries from 2018 until 2021. Erik has founded and served as board member of www.hpcfinance.eu and www.bigdatafinance.eu, the European initiatives from 2011 until 2019 on high performance computing and big data analytics in financial services.

Erik graduated as Chemical Engineer at Universiteit Gent (Belgium) and completed his MBA at London Business School in 2000. Prior to his MBA, Erik held R&D, production and strategy positions in the petrochemical industry in France, Belgium, Germany, the US and the UK. He is adviser to the Chemical Engineering Department of University College London on research and education.

Agenda Sessions

  • Governance: Board engagement on climate-related risks

    11:30